Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
270studies shown
Showing 85-96 of 270
Behavioral study icon
RecruitingNCT07171463

Pulsed Field Ablation With Concomitant Radiofrequency Cardioneuroablation in people with Paroxysmal Atrial Fibrillation

This study is looking at evaluate whether adjunctive thermal ablation improves clinical outcomes and reduces intraprocedural bradyarrhythmic events for people with Atrial Fibrillation. Taking part may give some people access to Pulmonary Vein Isolation using Point-by-Point Bipolar Pulsed-Field Ablation, but direct benefit is not guaranteed.

In Rzeszów
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralOver 18 Years
Countries
Poland
Sponsor
St. Joseph's Centre, Poland
Condition
Bipolarity
Other study type icon
RecruitingISRCTN54234300

ThrIVe-B feasibility study

This study is looking at whether a digital support tool can help people with Frequent mood swings within the context of a Bipolar Spectrum Disorder or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Bipolarity.

BipolarityOtherOver 18 Years
Countries
United Kingdom
Sponsor
Devon Partnership NHS Trust
Condition
Bipolarity
Drug study icon
RecruitingNCT07172516

Azetukalner for depression in bipolarity

This study is recruiting in the United States. It is testing azetukalner for depression in bipolarity.

Multiple locations, including Tucson
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States
Sponsor
Xenon Pharmaceuticals Inc.
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT07220460

Adverse Events of Oral ABBV-932 for depression

This study is recruiting in the United States. It is testing Adverse Events of Oral ABBV-932 for depression.

Multiple locations, including Phoenix
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
AbbVie
Condition
Bipolarity, Depression
Behavioral study icon
RecruitingNCT06488573

PROgram To Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolarity

This study is looking at whether a digital support tool can help people with Depression in bipolarity or bipolarity. Participants take part in a digital support tool and complete follow-up assessments.

In São Paulo
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionBehavioralFrom 18 Years to 60 Years
Countries
Brazil
Sponsor
University of Sao Paulo
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT05064319

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

This study is comparing Gabapentin with placebo for people with bipolarity. Participants receive Gabapentin or placebo and complete study visits and assessments.

In Charleston
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, Addiction, ...DrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Bipolarity, Addiction, ...
Drug study icon
RecruitingNCT04777357

Change for depression

This study is recruiting in the United States and in Russia. It is testing change for depression.

Multiple locations, including Bentonville
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 10 Years to 17 Years
Countries
United States, Russia
Sponsor
AbbVie
Condition
Bipolarity, Depression
Behavioral study icon
RecruitingNCT07213492

Multimodal Intervention to Support Hospital-to-Community Transition in Bipolarity

This observational study is following people with bipolarity or Psychosis to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Hamilton
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaBehavioralFrom 18 Years to 35 Years
Countries
Canada
Sponsor
McMaster University
Condition
Bipolarity, Schizophrenia
Other study type icon
RecruitingNCT07211217

Time Restricted Eating (TRE) in Bipolarity

This study is looking at whether Time Restricted Eating can help people with bipolarity, bipolarity Depression, or Overweight. Participants take part in Time Restricted Eating and complete follow-up assessments.

In Boston
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity, Depression
Other study type icon
RecruitingISRCTN97160532

SMRI-02T-162A: double blind placebo controlled study of a protein kinase C inhibitor: tamoxifen citrate in treatment of acute mania

This study is recruiting in the United States and in Türkiye. It focuses on Bipolarity.

In Turkey
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaOtherOver 18 Years
Countries
United States, Türkiye
Sponsor
The Stanley Medical Research Institute (SMRI) (USA)
Condition
Bipolarity, Schizophrenia
Behavioral study icon
RecruitingNCT06560957

SYNCED - SYNChronized Eating in Depression in bipolarity Study

This study is looking at whether a digital support tool can help people with Depression in bipolarity, Bipolarity I, or Bipolarity II. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

In Ottawa
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionBehavioralFrom 18 Years to 55 Years
Countries
Canada
Sponsor
University of Ottawa
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT06706232

Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolarity II Depression and Suicide prevention

This study is looking at whether questionnaires and follow-up can help people with Bipolarity II, Depression in bipolarity, or Suicide prevention. Participants receive a study treatment and complete follow-up visits and assessments.

In Houston
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, Depression, ...DrugFrom 25 Years to 70 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Bipolarity, Depression, ...
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.